Physician profile
Eric Fels
NPI 1821089590
$1,563.25
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.16 · 2020: $19.02 · 2021: $1,120 · 2022: $278 · 2023: $15.58 · 2024: $78.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $93.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $93.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,362.38 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $110.35 | 2019-2023 | |
| Mozarc Medical US LLC | $26.90 | 2024 | Argyle |
| Otsuka America Pharmaceutical, INC. | $18.64 | 2024 | Jynarque |
| Fresenius USA Marketing, INC. | $17.46 | 2024 | Velphoro |
| Ardelyx, INC. | $15.25 | 2024 | Ibsrela |
| Covidien Lp | $12.27 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Fels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.